Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Increases 2024 Treatment Site Activation Guidance to 20 Sites
QUEENSBURY, N.Y., March 26, 2024 /PRNewswire/ -- Delcath Systems, Inc. , an interventional oncology company focused on the treatment of...

Related Keywords

United States ,Ben Shamsian ,Gerard Michel ,Prnewswire Delcath Systems Inc ,Delcath Systems Inc ,Nasdaq ,Centers For Medicare Medicaid Services ,Exchange Commission ,Moffitt Cancer Center ,Site Activation Guidance ,Medicaid Services ,Chief Operating Officer ,Hepatic Delivery System ,Selective Internal Radiation Therapy ,Life After Melphalan Hepatic Perfusion ,Chief Executive ,Full Year ,Delcath Systems ,Prescribing Information ,Delivery System ,Private Securities Litigation Reform Act ,Mitigation Strategy ,Relations Contact ,Stockholder Equity ,Comprehensive Loss ,